Nonetheless, given the rare incidence of FH somatic alterations reported to this date in RCC16, it remains unclear whether the clinical behaviour of a FH-deficient RCC due to somatic alterations resembles that of HLRCC. This evidence concerns the gene FH and renal cell carcinoma.